As a clinical fellow in biochemical genetics at Johns Hopkins, Wedad Fallatah conducts research focused on the diagnosis and treatment of children with rare genetic disorders
Cuts to NIH funding for biostatistical research would erode the United States' competitive edge, hindering the health, economy, and overall security of the nation
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins
NIH clinical trials are a lifeline for cancer patients like Baltimore native Vanessa, who received a groundbreaking immunotherapy treatment at the Kimmel Cancer Center
America's biomedical research engine has produced lifesaving treatments for cancer and other diseases. Cuts to funding harm the lives and futures of Americans.
Backed by federal funding, Emily Boss, director of pediatric otolaryngology at Johns Hopkins Medicine, studies how communication between doctors, patients, and families shapes medical decisions and affects health outcomes